Sign in Create account

Source Natural Foods & Herbal Suppl Ltd

Healthcare · Pharmaceuticals & Biotechnology

BSE: 531398
₹108.50
▲ 0.50 (0.46%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
62/100
Moderate
Valuation
77/100
Undervalued
Momentum
65/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹70 Cr
PE (TTM)
18.7
Industry median 36.1 (152 companies)
Price to Book
2.7
PEG (TTM)
0.9
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-42.1
Free Cash Flow
₹-3 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
17.35%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
-7.13%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
63.09%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
17.14%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
77.02%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
2.18
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.30
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
7.67
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
3.45%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
5.95%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
7.31%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
6.80%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
21.08%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
10.80%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.30)
  • No Return on equity is 15% or more (10.8%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

3 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Undervalued (below its own historical PE range))
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • Yes Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.5%
Low 104.1000 · High 108.9000
1W return
-3.9%
Low 103.1000 · High 120.0000
1M return
-3.0%
Low 103.0000 · High 120.0000
52W return
-42.1%
Low 100.0000 · High 121.0000
Lifetime High ₹220.0000 (Nov. 1, 2017)
Lifetime Low ₹1.5100 (March 24, 2009)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish2
Bearish4
5D
108.9
10D
109.7
20D
110.4
50D
111.0
100D
107.3
200D
98.9

Delivery and volume

Day avg. delivery
82.0%
Week avg. delivery
84.6%
Month avg. delivery
80.7%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

107.17
Pivot
First resistance110.23
Second resistance111.97
Third resistance115.03
First support105.43
Second support102.37
Third support100.63
Day RSI45.3
Day MFI43.4
Day MACD-1.09
Day MACD signal-1.12

Beta

1M0.20
3M-0.03
1Y-0.03
3Y0.86

Price change analysis

↓ -3.0%
Over 1 Month
LowHigh
103.00120.00
↓ -42.1%
Over 3 Months
LowHigh
100.00121.00
↓ -42.1%
Over 6 Months
LowHigh
100.00121.00
↓ -42.1%
Over 1 Year
LowHigh
100.00121.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 18.7 (own history: 32.3–57.0)
Undervalued (below its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹21 Cr
Net profit (June 30, 2026)
₹1 Cr
Basic EPS (June 30, 2026)
₹1.1500

Ranks #147 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter74.37%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 74.37% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 61 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
29 Aug 2024 GUTTIKONDA RAJASEKHAR Bulk Buy 40,429 220.0000 BSE
19 Jul 2024 GUTTIKONDA VARA LAKSHMI Bulk Buy 40,884 174.6700 BSE
1 Jul 2024 GUTTIKONDA VARA LAKSHMI Bulk Buy 59,359 182.2300 BSE
27 Jun 2024 GUTTIKONDA VARA LAKSHMI Bulk Buy 38,375 140.0500 BSE
26 Jun 2024 HALDIA PRECISION ENGG P LTD Bulk Sell 47,774 120.1700 BSE
25 Jun 2024 VIKRAMKUMAR KARANRAJ SAKARIA HUF Bulk Buy 900 127.2800 BSE
25 Jun 2024 VIKRAMKUMAR KARANRAJ SAKARIA HUF Bulk Sell 32,300 124.4700 BSE
25 Jun 2024 HALDIA PRECISION ENGG P LTD Bulk Sell 67,726 122.9100 BSE
6 Oct 2020 HALDIA PRECISION ENGG P LTD Bulk Buy 36,000 120.5500 BSE
7 Mar 2013 INDERGIRI FINANCE LIMITED Bulk Buy 26,407 10.7500 BSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from INWINEX PHARMACEUTICALS LTD. to Source Natural Foods & Herbal Suppl Ltd

All corporate actions →

Corporate Announcements

All 7 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 AGM/EGM Source Natural Foods and Herbal Supplements Ltd - 531398 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
1 Oct 2026 Company Update Source Natural Foods and Herbal Supplements Ltd - 531398 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
30 Sep 2026 AGM/EGM Source Natural Foods and Herbal Supplements Ltd - 531398 - Shareholder Meeting / Postal Ballot-Outcome of AGM
30 Sep 2026 Insider Trading / SAST Source Natural Foods and Herbal Supplements Ltd - 531398 - Closure of Trading Window
10 Sep 2026 Company Update Source Natural Foods and Herbal Supplements Ltd - 531398 - Announcement under Regulation 30 (LODR)-Newspaper Publication
8 Sep 2026 Company Update Source Natural Foods and Herbal Supplements Ltd - 531398 - Notice Of 31St Annual General Meeting
8 Sep 2026 Others Source Natural Foods and Herbal Supplements Ltd - 531398 - Reg. 34 (1) Annual Report.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Healthy liquidity (Current Ratio 2.18)
  • Strong revenue growth YoY (77.0%)

Weaknesses

  • Thin net profit margin (3.4%)

Opportunities

  • PEG below 1 (0.92) -- earnings growth outpacing its own valuation

Threats

  • Down 42.1% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Source Natural Foods & Herbal Suppl Ltd

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.